Globus Medical (GMED) FCF Margin (2011 - 2026)

Globus Medical's FCF Margin history runs 16 years deep, the most recent figure standing at 21.42% for Q1 2026.

• Quarterly FCF Margin fell 219.0% year-over-year to 21.42% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 19.68% (down 536.0% YoY) and the FY2025 annual result came in at 20.03%, down 26.0% from the prior year.
• FCF Margin was 21.42% for Q1 2026 at Globus Medical, down from 24.49% in the prior quarter.
• Across five years, FCF Margin topped out at 45.55% in Q4 2024 and bottomed at 2.63% in Q2 2023.
• A 5-year average of 15.43% and a median of 13.49% in 2025 frame the typical range for FCF Margin.
• Annual changes were most pronounced in 2024 — FCF Margin soared 3228 bps — and 2025, when it sank 2106 bps.
• Globus Medical's FCF Margin stood at 16.62% in 2022, then fell by 20 bps to 13.27% in 2023, then surged by 243 bps to 45.55% in 2024, then slumped by 46 bps to 24.49% in 2025, then decreased by 13 bps to 21.42% in 2026.
• Business Quant data shows GMED's FCF Margin at 21.42% in Q1 2026, 24.49% in Q4 2025, and 18.81% in Q3 2025.